168 related articles for article (PubMed ID: 14729220)
21. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
[TBL] [Abstract][Full Text] [Related]
22. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
Dawson LA; Nguyen HQ
Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo.
Clifford EM; Gartside SE; Umbers V; Cowen PJ; Hajós M; Sharp T
Br J Pharmacol; 1998 May; 124(1):206-12. PubMed ID: 9630361
[TBL] [Abstract][Full Text] [Related]
24. Human sleep EEG following the 5-HT1A antagonist pindolol: possible disinhibition of raphe neuron activity.
Seifritz E; Stahl SM; Gillin JC
Brain Res; 1997 Jun; 759(1):84-91. PubMed ID: 9219866
[TBL] [Abstract][Full Text] [Related]
25. Pindolol increases extracellular 5-HT while inhibiting serotonergic neuronal activity.
Fornal CA; Martín FJ; Mendlin A; Metzler CW; Bjorvatn B; Jacobs BL
Eur J Pharmacol; 1999 Jul; 377(2-3):187-91. PubMed ID: 10456429
[TBL] [Abstract][Full Text] [Related]
26. Harmane inhibits serotonergic dorsal raphe neurons in the rat.
Touiki K; Rat P; Molimard R; Chait A; de Beaurepaire R
Psychopharmacology (Berl); 2005 Nov; 182(4):562-9. PubMed ID: 16133137
[TBL] [Abstract][Full Text] [Related]
27. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Béïque J; de Montigny C; Blier P; Debonnel G
Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
[TBL] [Abstract][Full Text] [Related]
28. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine.
Le Poul E; Laaris N; Doucet E; Laporte AM; Hamon M; Lanfumey L
Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):141-8. PubMed ID: 7477436
[TBL] [Abstract][Full Text] [Related]
29. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
Moser PC; Sanger DJ
Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation.
Sprouse JS; Reynolds LS; Braselton JP; Rollema H; Zorn SH
Neuropsychopharmacology; 1999 Nov; 21(5):622-31. PubMed ID: 10516958
[TBL] [Abstract][Full Text] [Related]
31. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
[TBL] [Abstract][Full Text] [Related]
32. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies.
Sprouse J; Braselton J; Reynolds L; Clarke T; Rollema H
Synapse; 2001 Jul; 41(1):49-57. PubMed ID: 11354013
[TBL] [Abstract][Full Text] [Related]
33. 5-HT1A receptor-mediated autoinhibition does not function at physiological firing rates: evidence from in vitro electrophysiological studies in the rat dorsal raphe nucleus.
Johnson DA; Gartside SE; Ingram CD
Neuropharmacology; 2002 Nov; 43(6):959-65. PubMed ID: 12423665
[TBL] [Abstract][Full Text] [Related]
34. The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing.
Arborelius L; Wallsten C; Ahlenius S; Svensson TH
Eur J Pharmacol; 1999 Oct; 382(2):133-8. PubMed ID: 10528148
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors.
Dreshfield LJ; Wong DT; Perry KW; Engleman EA
Neurochem Res; 1996 May; 21(5):557-62. PubMed ID: 8726963
[TBL] [Abstract][Full Text] [Related]
36. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
Haddjeri N; Blier P
J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
[TBL] [Abstract][Full Text] [Related]
37. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
[TBL] [Abstract][Full Text] [Related]
38. Relevance of dorsal raphe nucleus firing in serotonin 5-HT(2C) receptor blockade-induced augmentation of SSRIs effects.
Sotty F; Folgering JH; Brennum LT; Hogg S; Mørk A; Hertel P; Cremers TI
Neuropharmacology; 2009 Jul; 57(1):18-24. PubMed ID: 19376075
[TBL] [Abstract][Full Text] [Related]
39. Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons.
Mongeau R; Weiss M; de Montigny C; Blier P
Neuropharmacology; 1998 Jul; 37(7):905-18. PubMed ID: 9776386
[TBL] [Abstract][Full Text] [Related]
40. GABA(B) receptors in the median raphe nucleus: distribution and role in the serotonergic control of hippocampal activity.
Varga V; Sik A; Freund TF; Kocsis B
Neuroscience; 2002; 109(1):119-32. PubMed ID: 11784704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
